
Sofokast 400mg Tablet
Salt Composition: Sofosbuvir
Expiry Date: 01/2028
Inclusive of all taxes
28 Tablet
About The Product
Hepatitis C, Viral Infection
Sofokast 400mg Tablet belongs to the category of Hepatitis medicines. These medicines are primarily used to treat patients diagnosed with the hepatitis C virus (HCV) infection. The active ingredient of the Sofokast is Sofosbuvir, which belongs to the drug class of direct-acting antivirals (DAAs). It is taken orally with or without food as per the doctor's advice. Sofokast treats specific genotypes of hepatitis C in certain people, and in some cases also used for HIV treatment, whereas it is not a treatment for HIV or AIDS.
Side Effects
- Like most anticancer drugs, Sofokast 400mg Tablet may cause some adverse effects on the body during the treatment.
- These can vary from mild to severe depending on the dose and the patient’s health condition.
- Common side effects include: Fever Nausea Joint pain Vomiting Fatigue Abdominal pain Poor appetite Itching Dark yellow urine & stools Jaundice Pale skin Unusual tiredness Feeling light-headed Difficulty breathing Cold hands and feet Inform your doctor immediately if you experience any persistent or unusual side effects.
How To Use
- Sofokast 400mg Tablet is a prescription-based hepatitis drug that should be administered orally.
- It is advised to take this tablet with or without food as per the doctor's advice.
- It should be taken at the same time every day for effective results.
- The required dosage and duration of the medicine are decided by the doctor as per medical history, age, health condition, and the body's response to the treatment.
- Taking it in the wrong way or overdosing can cause severe side effects.
- It may take weeks for patients to notice the benefits of the medicine.
- So do not stop taking this tablet until your doctor says to do so.
- Sofokast is given as a combination therapy with other antiviral medications to treat chronic hepatitis C in adults, and it should not be used alone.
How It Works
The active ingredient of the Sofokast is Sofosbuvir, which belongs to the drug class of direct-acting antivirals (DAAs). Sofokast Tablet works by eliminating the virus completely from the human body.
In this way, it prevents the infection from spreading to other parts of the body. This tablet blocks the protein required for replication and assembly of new virus particles.
Once this protein gets blocked, the virus multiplication process stops automatically. It also prevents new virus particles from forming and reduces the viral load in the body.
Safety Advice
Missed Doses
- It is advised not to miss any scheduled dosage of Sofokast 400mg tablet.
- In case you miss a dose, consult your doctor immediately.
- Don't overdose to compensate for the missed one.
- Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
Quick Tips
• Go for a liver function test once you start the treatment to ensure normal functioning of the organ.
• Do not share your medicine with other people, as some medicines treat specific genotypes of Hepatitis.
• Some Hepatitis medicines are given in combination with other antiviral drugs. So, it is advised not to use them alone.
• Hepatitis medicines are given to treat HIV/ AIDS patients in some cases. But these medicines are not the proper treatment for this disease.
• It is advised to use effective birth control methods to avoid pregnancy. Some hepatitis drugs can cause birth defects, miscarriage, or death to an unborn baby if the mother or father is using this medicine.
• It is advised to tell your doctor about all medicines (multivitamins, herbal supplements) you're taking currently before starting your course with hepatitis medicines. There are chances that many drugs can interact, and some drugs should not be used together.
FAQs
Sofokast is used to treat patients diagnosed with chronic Hepatitis C virus (HCV) infection.
This medicine is usually given in combination with other antiviral medicines.
Reference
1. Asselah, T.
(2014). Sofosbuvir for the treatment of hepatitis C virus.
Expert opinion on pharmacotherapy, 15(1), 121-130. 2.
Keating, G. M., & Vaidya, A.
(2014). Sofosbuvir: first global approval.
Drugs, 74(2), 273-282. 3.
Lawitz, Eric, Alessandra Mangia, David Wyles, Maribel Rodriguez-Torres, Tarek Hassanein, Stuart C. Gordon, Michael Schultz et al.
"Sofosbuvir for previously untreated chronic hepatitis C infection." New England Journal of Medicine 368, no. 20 (2013): 1878-1887.
4. Keating, G.
M. (2014).
Sofosbuvir: a review of its use in patients with chronic hepatitis C. Drugs, 74(10), 1127-1146.
5. Foster, G.
R., Afdhal, N., Roberts, S. K., Bräu, N., Gane, E.
J., Pianko, S., ... & Sulkowski, M. (2015).
Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection. New England Journal of Medicine, 373(27), 2608-2617.
6. Feld, J.
J., Jacobson, I. M., Hézode, C., Asselah, T., Ruane, P.
J., Gruener, N., ... & Zeuzem, S. (2015).
Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection. New England Journal of Medicine, 373(27), 2599-2607.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
